VONOPRAZAN, A NOVEL ACTIVE POTASSIUM-COMPETITIVE ACID BLOCKER, AND RABEPRAZOLE INDUCE SMALL INTESTINAL DYSBIOSIS AND EXACERBATE THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED SMALL INTESTINAL ENTEROPATHY
VONOPRAZAN, A NOVEL ACTIVE POTASSIUM-COMPETITIVE ACID BLOCKER, AND RABEPRAZOLE INDUCE SMALL INTESTINAL DYSBIOSIS AND EXACERBATE THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED SMALL INTESTINAL ENTEROPATHY
复制标题
沃诺拉赞（一种新型活性钾竞争性酸阻滞剂）和雷贝拉唑可引起小肠失调并加剧非甾体抗炎药物引起的小肠肠病
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Nadatani Y;Watanebe T;Sugimura N;et al.
